Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1989-8-14
|
pubmed:abstractText |
Tissue plasminogen activator labeled with radioactive iodine (125I-tPA) was immobilized on vascular prostheses chemically modified with a thin coating of water-insoluble surfactant, tridodecylmethylammonium chloride (TDMAC). Surfactant-treated Dacron, polytetrafluoroethylene (PTFE), silastic, polyethylene and polyurethane bound appreciable amounts of 125I-tPA (5-30 micrograms 125I-tPA/cm2). Upon exposure to human plasma, the amount of 125I-tPA bound to the surface shows an initial drop during the first hour of incubation, followed by a slower, roughly exponential release with a t 1/2 of approximately 75 hours. Prostheses containing bound tPA show fibrinolytic activity as measured both by lysis of clots formed in vitro, and by hydrolysis of a synthetic polypeptide substrate. Prior to incubation in plasma, tPA bound to a polymer surface has an enzymic activity similar, if not identical to that of the native enzyme in buffered solution. However, exposure to plasma causes a decrease in the fibrinolytic activity of both bound tPA and enzyme released from the surface of the polymer. These data demonstrate that surfactant-treated prostheses can bind tPA, and that these chemically modified devices can act as a slow-release drug delivery system with the potential for reducing prosthesis-induced thromboembolism.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/Chromogenic Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Oligopeptides,
http://linkedlifedata.com/resource/pubmed/chemical/Polymers,
http://linkedlifedata.com/resource/pubmed/chemical/Quaternary Ammonium Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Surface-Active Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Tissue Plasminogen Activator,
http://linkedlifedata.com/resource/pubmed/chemical/tridodecylmethylammonium
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0340-6245
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
28
|
pubmed:volume |
61
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
131-6
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2501890-Antigens,
pubmed-meshheading:2501890-Blood Vessel Prosthesis,
pubmed-meshheading:2501890-Chromogenic Compounds,
pubmed-meshheading:2501890-Humans,
pubmed-meshheading:2501890-Oligopeptides,
pubmed-meshheading:2501890-Polymers,
pubmed-meshheading:2501890-Quaternary Ammonium Compounds,
pubmed-meshheading:2501890-Surface Properties,
pubmed-meshheading:2501890-Surface-Active Agents,
pubmed-meshheading:2501890-Thrombelastography,
pubmed-meshheading:2501890-Tissue Plasminogen Activator
|
pubmed:year |
1989
|
pubmed:articleTitle |
Binding of tissue plasminogen activator to vascular grafts.
|
pubmed:affiliation |
Department of Biochemistry, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854.
|
pubmed:publicationType |
Journal Article
|